This series investigates cannabinoids and pharmaceutical interest with industry experts explaining the position of the ingredient. In this second piece, we discuss the challenges, legal implications and perceptions of cannabinoids.

Learn how Raman microscopy can help solve some of the biggest challenges in 3D imaging and microparticle analysis.

A warning letter has been sent to Emcure Pharmaceuticals after an FDA facility inspection found that the company did not adequately investigate sterility failures.

The FDA has accepted an IND application for AG017, a new drug designed to treat the causes of coeliac disease which will soon enter new trials.

The pharmaceutical company has received a complete response letter for its golodirsen injection, which had been submitted for accelerated approval.